Recently, the FDA has been providing much heavier guidance - and more Form 483s for objectionable conditions - with respect to the regulatory requirements of cGMP controlled raw materials.
Maintaining standards and best practices surrounding cGMP guidelines are critical for those in the pharmaceutical industry. Learn more about these regulations and how MediZap can help keep you ahead of the curve.